Navigation path

Themes
Agriculture & food
Energy
Environment
ERA-NET
Health & life sciences
Human resources & mobility
Industrial research
Information society
Innovation
International cooperation
Nanotechnology
Pure sciences
Research infrastructures
Research policy
Science & business
Science in society
Security
SMEs
Social sciences and humanities
Space
Special Collections
Transport

Countries
Countries
  Argentina
  Australia
  Austria
  Belarus
  Belgium
  Brazil
  Bulgaria
  Cameroon
  Canada
  Chile
  China
  Colombia
  Croatia
  Cyprus
  Czech Republic
  Denmark
  Egypt
  Estonia
  Finland
  France
  Georgia
  Germany
  Ghana
  Greece
  Hungary
  Iceland
  India
  Ireland
  Israel
  Italy
  Japan
  Kazakhstan
  Kenya
  Korea
  Latvia
  Lithuania
  Luxembourg
  Macedonia - former Yugoslav Republic
  Malta
  Mexico
  Montenegro
  Morocco
  Namibia
  Netherlands
  Nigeria
  Norway
  Peru
  Poland
  Portugal
  Romania
  Russia
  Serbia
  Slovakia
  Slovenia
  South Africa
  Spain
  Swaziland
  Sweden
  Switzerland
  Taiwan
  Tunisia
  Turkey
  Ukraine
  United Kingdom
  United States


   All

Last Update: 31-01-2014  
Related category(ies):
Health & life sciences  |  Success stories  |  International cooperation

 

Countries involved in the project described in the article:
Belgium  |  Denmark  |  France  |  Germany  |  Italy  |  Korea  |  Netherlands  |  Spain  |  Switzerland  |  United Kingdom
Add to PDF "basket"

Tuberculosis: An injection of hope

Tuberculosis still turns some people’s lives to hell. At a pharmaceutical lab near a hospital in Spain, scientists from a European Union research project are trying to find answers to the complex and often dramatic challenges posed by the disease.

Photo of Doctors examining a patient
Video in QuickTime format:  ar  de  en  es  fa  fr  el  it  pt  ru  tr  uk  (10.2 MB)

Tuberculosis still turns some people’s lives to hell. One of them is Alfredo Cabaleiro Besada, from Spain.

He said: “After being diagnosed with tuberculosis, I had two options; first, a long stay in a hospital room where nobody could visit me without wearing a special mask.

“Second, staying secluded at home and coming here to the hospital every day for treatment, a daily injection and 22 pills that I also had to take daily in the presence of a nurse.

“I opted for this second option. If ever I had to go outside, to the bakery or other places, I always had to wear a mask.”

Alfredo recovered, but TB still kills 1.5 million people every year worldwide and around 100,000 new cases are diagnosed every year in Europe.

At a pharmaceutical lab near the hospital, scientists from a European Union research project are trying to find answers to the complex and often dramatic challenges posed by the disease.

The project’s first result is a new candidate vaccine, produced at these research facilities.

Unlike the only existing, 100-year-old tuberculosis vaccine, this is a live vaccine based on a weakened version of the bacterium that causes the disease.

Researchers hope this will make the vaccine safer and more effective though it poses huge challenges for its fabrication.

Some 1,800 kilometers from Vigo, in Lausanne, Switzerland the first clinical trials using real volunteers have begun.

At this stage, doctors and researchers want to evaluate the candidate vaccine’s safety and also to get an accurate first impression of how efficient it could be to stimulate some molecules thought to protect the human body against the disease.

Provided that it successfully passes the 3 clinical trials needed for scientific validation, researchers hope that industrial production of the new vaccine could start in around ten years.

Project details

  • Project acronym:NEWTBVAC
  • Participants: Netherlands (Coordinator),Italy, UK, Switzerland, Spain, Germany, Belgium, Korea, France, Denmark
  • FP7 Project N° 231640
  • Total costs: €18 875 943
  • EU contribution: €11 996 730
  • Duration: January 2010 - February 2014

Convert article(s) to PDF

No article selected


loading


Search articles
To restrict search results to articles in the Information Centre, i.e. this site, use the search box at the top of the page to the right of the menu and then select "Information Centre" in the "Filter by" menu on the results page.

Please note that new content may take a few days to be indexed by the search engine and therefore to appear in the results.

Print Version
Share this article
See also

Futuris, the European research programme - on Euronews. The video on this page was prepared in collaboration with Euronews for the Futuris programme.

Project web site

Project information on CORDIS

Contacts
Unit A1 - External & internal communication,
Directorate-General for Research & Innovation,
European Commission
Tel : +32 2 298 45 40
  Top   Research Information Center